Bought 500 ITRM @$1.60 Target @$8.00 date Jan 10,2022
Item Therapeutics, Inc
Bought 500 ITRM @$1.60. Target @$8.00 date Jan 10,2022
Buy limit 500 ITRM @$1.40. Target @$10.00 date May 2,2022
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly
differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens.
Company Website: www.iterumtx.com/
Press Release: www.iterumtx.com/news/press-releases
FDA Aproval analysis review: youtu.be/EPgkP7wO8h4
Bought 500 ITRM @$1.60. Target @$8.00 date Jan 10,2022
Buy limit 500 ITRM @$1.40. Target @$10.00 date May 2,2022
Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly
differentiated anti-infectives aimed at combating the global crisis of multi-drug resistant (MDR) pathogens.
Company Website: www.iterumtx.com/
Press Release: www.iterumtx.com/news/press-releases
FDA Aproval analysis review: youtu.be/EPgkP7wO8h4